MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$4,986,614
Net loss
-$4,986,614
Interest income
(expense), net
$77,350
Sublease income
$19,455
Loss before income
taxes
-$4,985,421
Deferred income tax
expense
$1,193
Total other income
(expense)
$90,945
Exchange loss, net
-$5,860
Gain from operations
-$5,076,366
Total operating
expenses
$5,076,366
Research and development
$2,669,779
General and
administrative expenses
$2,406,587
Back
Back
Income Statement
source: myfinsight.com
Dogwood Therapeutics, Inc. (DWTX)
Dogwood Therapeutics, Inc. (DWTX)